Marla Shapiro C.M. | Medicine and Dentistry | Research Excellence Award

Dr. Marla Shapiro C.M. | Medicine and Dentistry | Research Excellence Award

Professor | University of Toronto | Canada

Dr. Marla Shapiro is an Associate Professor at the University of Toronto, Canada, specializing in menopause research, vasomotor symptoms, and women’s midlife health. Her scholarship focuses on advancing evidence-based, non-hormonal and hormonal therapeutic strategies for managing moderate to severe menopausal symptoms. She has published 34 peer-reviewed articles, receiving 1,713 citations, with an h-index of 14, demonstrating consistent academic influence. Dr. Shapiro has played a key role in international phase 3 and 3b clinical trials, including responder and pooled analyses of fezolinetant, published in leading journals such as Maturitas and Menopause. Through collaborations with more than 180 international co-authors, her work has informed clinical decision-making, supported guideline development, and contributed meaningfully to improving quality of life and healthcare outcomes for menopausal women worldwide.

Citation Metrics (Scopus)

1713
1200
800
400
0

Citations

1,713

Documents

34

h-index

14

Citations

Documents

h-index

View Scopus Profile
View ResearchGate Profile

Featured Publications

Ming-Yow Hung | Medicine and Dentistry | Research Excellence Award

Prof. Ming-Yow Hung | Medicine and Dentistry | Research Excellence Award

Professor | Shuang Ho Hospital, Taipei Medical University | Taiwan

Dr. Ming Yow Hung is a distinguished researcher at Taipei Medical University, Taiwan, specializing in cardiovascular biology, molecular cardiology, and stem cell research. His work focuses on understanding coronary artery disorders, including vasospasm, Kounis syndrome, and allergic myocardial infarction, through experimental, translational, and epigenetic approaches. He has authored numerous peer-reviewed publications, with significant citation impact reflecting his influence in cardiovascular and pharmaceutical research. Dr. Hung collaborates extensively with international teams, contributing to multidisciplinary studies that integrate molecular mechanisms, induced pluripotent stem cell models, and clinical insights. His research advances understanding of disease mechanisms and informs therapeutic strategies, with clear societal relevance in improving cardiovascular health, personalized medicine, and patient care, positioning him as a globally recognized and impactful scientist in cardiovascular research.

Citation Metrics (Scopus)

1,824
1,400
900
450
0

Citations

1,824

Documents

57

h-index

20

Citations

Documents

h-index

View Scopus Profile
View ORCID Profile

Featured Publications

Giuseppina Peluso | Medicine and Dentistry | Excellence in Research Award

Dr. Giuseppina Peluso | Medicine and Dentistry | Excellence in Research Award

Dirigente Responsabile | Azienda Ospedaliera | Italy

Dr. Giuseppina Peluso is a researcher at the AO of Cosenza in Italy, specializing in reproductive biology with an emphasis on the molecular and cellular mechanisms governing human sperm function. Her work explores the balance between pro-survival and pro-apoptotic pathways, offering deeper insight into the biological foundations of male infertility. Through sustained scientific contributions and broad interdisciplinary collaborations, she advances understanding of how molecular signaling influences sperm quality and reproductive potential. Her research supports the development of innovative therapeutic approaches and contributes to improving clinical strategies in andrology and reproductive health. Peluso’s commitment to evidence-based investigation continues to generate meaningful impact within both scientific and healthcare communities.

Citation Metrics (Scopus)

103
75
50
25
0

Citations

103

Documents

12

h-index

6

Citations

Documents

h-index

View Scopus Profile View ORCID Profile

Featured Publications

Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Dr. Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Specialist | University of health sciences | Turkey

Dr. Nermin Mutlu Bilgic is a Gastroenterology Specialist at the University of Health Sciences Ümraniye Training and Research Hospital in Istanbul, Türkiye. She earned her Doctor of Medicine degree from Istanbul University Cerrahpaşa Faculty of Medicine in 2004, completed her residency in Internal Medicine at Maltepe University between 2007 and 2012, and obtained her subspecialty in Gastroenterology at Ümraniye Training and Research Hospital from 2015 to 2019. With over fifteen years of academic and clinical experience, Dr. Bilgiç specializes in hepatology, metabolic liver diseases, and inflammatory gastrointestinal disorders. She has served as Principal Investigator for international multicenter clinical trials evaluating the efficacy and safety of Saroglitazar Magnesium in patients with Primary Biliary Cholangitis and Nonalcoholic Steatohepatitis, reflecting her active contribution to global research in liver diseases. She has received certified training in Good Clinical Practice (GCP) from Roche/Genentech and the Global Health Training Centre, ensuring compliance with international ethical and regulatory standards. Dr. Bilgiç has authored and co-authored peer-reviewed publications and presented her work at several national and international gastroenterology and internal medicine conferences. Her professional focus integrates patient-centered clinical care with translational research aimed at improving therapeutic outcomes and understanding the mechanisms of chronic liver disease. She is also actively engaged in mentoring residents and fellows, contributing to medical education and the advancement of clinical research culture within her institution. Through her leadership in clinical trials, scientific collaborations, and commitment to ethical medical practice, Dr. Nermin Mutlu Bilgiç continues to make a meaningful impact on the advancement of gastroenterology and hepatology in both national and international contexts.

Profiles: Google Scholar | ORCID

Featured Publications

Kul, S., Caliskan, Z., Guvenc, T. S., Celik, F. B., Sarmis, A., Atici, A., Konal, O., Akıl, M., & Bilgiç, N. M. (2023). Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with …. Microvascular Research, 146, 104458 Cited by 31

Sayar, S., Aykut, H., Kaya, Ö., Kürbüz, K., Ak, Ç., Gökçen, P., Bilgiç, N. M., Adalı, G., & others. (2021). Bone mineral density screening and the frequency of osteopenia/osteoporosis in Turkish adult patients with celiac disease. The Turkish Journal of Gastroenterology, 32(7), 600–606 Cited by 13

Sayar, S., Kürbüz, K., Kahraman, R., Öztürk, O., Çalışkan, Z., Doğanay, H. L., Bilgiç, N. M., & others. (2020). Risk of hepatitis B reactivation during anti-TNF therapy: Evaluation of patients with past hepatitis B infection. The Turkish Journal of Gastroenterology, 31(7), 522–528 Cited by 13

Ozdil, K., Ozturk, O., Çalık, E. S., Akbas, E. S., Kanat, E., Caliskan, Z., Demirdag, H., Bilgiç, N. M., & others. (2016). Relationship between size of varices and platelet count/spleen size ratio in cirrhotic patients. Northern Clinics of Istanbul, 3(1), 46–50 Cited by 11

Adali, G., Bilgiç, N. M., Kalaman, A. E., Ozturk, O., & Ozdil, K. (2023). Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study. Hepatology Forum, 4(3), 129–135 Cited by 8

 

Dr. Nermin Mutlu Bilgic work advances the understanding and management of chronic liver and metabolic diseases through evidence-based clinical research and international collaboration. Her contributions to hepatology and gastroenterology foster improved patient outcomes, support ethical research practices, and drive innovation in global liver health.

Valmir Rastely-Junior | Infectious Diseases | Young Scientist Award

Mr. Valmir Rastely-Junior | Infectious Diseases | Young Scientist Award

Universidade Federal da Bahia | Brazil

Mr. Valmir Rastely-Junior is a distinguished physician specializing in infectious diseases, pediatrics, and neuropediatrics, with an MD from the Federal University of Bahia (UFBA, 2015). He has accumulated extensive clinical and research experience, focusing on child health, congenital Zika syndrome, antimicrobial resistance, and public health inequities, integrating multidisciplinary care with evidence-based interventions. His professional trajectory includes work at Fiocruz Bahia on neurodevelopmental studies, epidemiologic surveillance, teratogen information services, and COVID-19 teleadvice programs. He has been instrumental in technology-driven initiatives such as Telecoronavírus (UFBA) and Artificial Intelligence as a Service for Combating COVID-19 (Rede CoVida/Cidacs Fiocruz), emphasizing the translation of research into practical, community-focused solutions. Mr. Rastely-Junior’s research interests center on infectious-disease–driven child health, neurodevelopmental outcomes in congenital infections, health disparities, and AI-supported clinical and epidemiological tools. He possesses strong research skills, including clinical study design, epidemiologic analysis, bibliometric synthesis, and international collaborative research, demonstrated through six peer-reviewed publications in Scopus and PubMed-indexed journals, three joint research projects, two conference presentations, and mentorship of research scholars. His work has earned eight awards and recognitions, including first-place honors at Fiocruz Bahia and an honorable mention in the International Balint Award/Ascona Prize, reflecting both scientific excellence and societal impact. Mr. Rastely-Junior is an active member of 16 professional bodies, contributing to editorial, review, and volunteer initiatives that promote knowledge dissemination and community engagement. In conclusion, his blend of clinical expertise, innovative research, international collaborations, and commitment to evidence-based public health positions him as a promising leader in global biomedical research, capable of advancing high-impact publications, AI-enabled solutions, and mentorship programs that enhance healthcare outcomes and scientific standards worldwide. 27 Citations | 3 Documents | 2 h-index.

Profiles: Google Scholar | Scopus | ORCID | LinkedIn

Featured Publications

  1. Aguilar Ticona, J. P., Nery Jr, N., Doss-Gollin, S., Gambrah, C., Lessa, M., … Rastely-Junior, V. N. (2021). Heterogeneous development of children with Congenital Zika Syndrome-associated microcephaly. PLoS One, 16(9), e0256444. https://doi.org/10.1371/journal.pone.0256444. Cited by: 26

  2. Nery Jr, N., Aguilar Ticona, J. P., Gambrah, C., Doss-Gollin, S., Aromolaran, A., … Rastely-Junior, V. N. (2021). Social determinants associated with Zika virus infection in pregnant women. PLoS Neglected Tropical Diseases, 15(7), e0009612. https://doi.org/10.1371/journal.pntd.0009612. Cited by: 14

  3. Aromolaran, A., Araujo, K., Ladines-Lim, J. B., Nery Jr, N., do Rosário, M. S., … Rastely-Junior, V. N. (2022). Unequal burden of Zika-associated microcephaly among populations with public and private healthcare in Salvador, Brazil. International Journal of Infectious Diseases, 120, 201–204. https://doi.org/10.1016/j.ijid.2022.06.021. Cited by: 6

  4. Mattos, A. M., Rastely-Junior, V. N., Pires, M. M., Aguilar, J. P., Lessa, M. S. A., Regis, C., … (2023). Predictors of neurodevelopment in microcephaly associated with congenital Zika Syndrome: A prospective study. Children, 10(12), 1831. https://doi.org/10.3390/children10121831. Cited by: 3

  5. Brito, L. B., Rastely-Junior, V. N., Browne, E. S., Nery Júnior, N. R. R., … (2016). Sinais e sintomas de zika-virus em gestantes internadas em um Hospital Público de referência da Bahia. Cited by: 2

 

Adriana Grigoras | Pathology | Best Researcher Award

Assoc. Prof. Dr. Adriana Grigoras | Pathology | Best Researcher Award

Grigoras at Grigore T. Popa University of Medicine and Pharmacy, Romania

Dr. Adriana Grigoraș is a distinguished Associate Professor and Senior Pathologist with extensive expertise in cancer biology, adipose tissue research, and pathology. With over 40 publications indexed in Web of Science and 14 book chapters published by prestigious publishers like Springer and Elsevier, she has demonstrated consistent scholarly impact. Her involvement in international research projects such as Erasmus+ and AMI-4EUROPE highlights her commitment to academic innovation and cross-border collaboration. She serves as a guest editor and reviewer for high-impact journals, further reflecting her leadership in the scientific community. Dr. Grigoraș has received four national awards and actively mentors future researchers, reinforcing her role as an academic leader. While citation metrics and translational outputs could be more explicitly stated, her record clearly showcases excellence in both research and education. Overall, her multidisciplinary contributions and strong academic presence make her a highly suitable candidate for the Best Researcher Award.

Professional Profile 

Education🎓

Dr. Adriana Grigoraș has a strong and comprehensive educational background rooted in medical sciences. She earned her Medical Degree (MD) from the prestigious “Grigore T. Popa” University of Medicine and Pharmacy in Iași, Romania, where she later completed her PhD in Medical Sciences. Demonstrating continued academic progression, she also achieved the title of Doctor Habilitatus (Dr. Habil.), a qualification that highlights her ability to lead independent research and supervise doctoral candidates. Her deep specialization in pathology is reinforced by her role as a Senior Pathologist at the same institution. This combination of clinical expertise and academic credentials positions Dr. Grigoraș as a highly competent medical educator and researcher. Her educational journey reflects a strong commitment to both advancing medical knowledge and applying it in practical, research-driven contexts. Through her academic achievements, she has laid a solid foundation for her impactful work in teaching, mentoring, and biomedical research.

Professional Experience📝

Dr. Adriana Grigoraș has a rich professional background that combines academic excellence with clinical expertise. She currently serves as an Associate Professor in the Morphofunctional Sciences Department at the “Grigore T. Popa” University of Medicine and Pharmacy in Iași, Romania, where she is deeply involved in teaching, mentoring, and supervising research. In parallel, she holds the position of Senior Pathologist at the Institute of Legal Medicine in Iași, contributing her diagnostic expertise to forensic and clinical pathology. Her dual roles reflect a unique integration of theoretical knowledge and practical application, enhancing both her educational impact and scientific research. Dr. Grigoraș has actively participated in international research initiatives, including Erasmus+ and AMI-4EUROPE projects, emphasizing her commitment to innovation and interdisciplinary collaboration. Her extensive experience in academic publishing, guest editing, and peer reviewing further showcases her leadership within the scientific community, making her a respected figure in both academic and medical fields.

Research Interest🔎

Dr. Adriana Grigoraș’s research interests span a diverse and impactful range of biomedical fields, reflecting her multidisciplinary expertise. She is particularly focused on the role of adipose tissue in human pathology, with a strong emphasis on obesity-related diseases and its link to carcinogenesis. Her work delves deeply into tumor pathology, including the tumor microenvironment and cancer stem cells, aiming to uncover new diagnostic markers and therapeutic targets. She is also engaged in research on cardiovascular pathology, exploring how perivascular and perirenal adipose tissue contribute to disease mechanisms. In addition, Dr. Grigoraș has a strong interest in forensic pathology, applying advanced histopathological and immunohistochemical techniques to better understand causes of death, including hypothermia-related fatalities. Her research bridges clinical, experimental, and translational approaches, addressing both fundamental science and practical medical challenges. This broad yet focused research profile positions her at the forefront of modern biomedical investigation, particularly in cancer and metabolic disease research.

Award and Honor🏆

Dr. Adriana Grigoraș has been recognized for her outstanding contributions to medical research and academia through multiple national awards, reflecting the high esteem in which she is held by the scientific and medical communities. These honors acknowledge her impactful work in cancer biology, pathology, and medical education. In addition to her awards, she has gained notable recognition as a guest editor for several special issues in respected international journals such as Biomedicines and Pharmaceuticals, focusing on topics like tumor microenvironment, cancer therapy, and obesity-related pathology. Her role as a member of the reviewer board for Biomedicines further demonstrates her standing as a trusted expert in her field. These honors not only highlight her scientific excellence and leadership but also her dedication to advancing knowledge through rigorous peer review and editorial responsibilities. Collectively, Dr. Grigoraș’s awards and distinctions underscore her strong candidacy for continued recognition in research and academic achievement.

Research Skill🔬

Dr. Adriana Grigoraș possesses exceptional research skills that span a wide range of biomedical and clinical disciplines. Her expertise is evident in her extensive body of work, including over 40 publications indexed in the Web of Science and 14 contributions to books and book chapters with renowned publishers such as Springer and Elsevier. She demonstrates advanced proficiency in experimental design, histopathological analysis, and scholarly writing, with a focus on cancer biology, adipose tissue pathology, and the tumor microenvironment. Dr. Grigoraș is adept at integrating clinical observations with molecular and cellular research to generate meaningful insights, particularly in oncology and cardiovascular diseases. She is also experienced in interdisciplinary collaboration, having participated in international research projects like Erasmus+ and AMI-4EUROPE. Her skills extend to mentoring and supervising, where she guides students and junior researchers in developing their own scientific capabilities. Overall, her research skills reflect depth, precision, and a commitment to scientific advancement.

Conclusion💡

Dr. Adriana Grigoraș is a highly accomplished researcher with a strong profile that blends deep subject-matter expertise, international collaboration, editorial leadership, and a rich publication record. Her contributions to cancer biology, adipose tissue research, and pathology position her as a competitive candidate for the Best Researcher Award.

While there is room to further highlight quantitative impact metrics and innovation outputs, her scholarly excellence, multidisciplinary involvement, and editorial leadership clearly qualify her as a top-tier contender for this recognition.

Recommendation: Highly Suitable for the Best Researcher Award.

Publications Top Noted✍

  • Title: The Role of Perirenal Adipose Tissue in Carcinogenesis—From Molecular Mechanism to Therapeutic Perspectives

    Authors: Adriana Grigoraș, Cornelia Amălinei

    Year: 2025

    Type: Review • Open Access

  • Title: Clinicopathological and Molecular Landscape in Colorectal Cancer Associated with Colorectal Polyps and Inflammatory Bowel Disease

    Authors: Diana Lavinia Pricope, Adriana Grigoraș, Constantin Aleodor Costin, Cornelia Amălinei

    Journal: Romanian Journal of Morphology and Embryology

    Year: 2024

    Type: Article • Open Access

  • Title: Are HPV Oncogenic Viruses Involved in Salivary Glands Tumorigenesis?

    Authors: Constantin Aleodor Costin, Mariana Bianca Chifu, Diana Lavinia Pricope, Raluca Anca Bălan, Cornelia Amălinei

    Year: Not specified (assumed recent, likely 2024)

    Type: Review • Open Access

  • Title: Advanced Diagnostic Tools in Hypothermia-Related Fatalities—A Pathological Perspective

    Authors: Andreea Alexandra Velnic, Adriana Grigoraș, Victor Ianole, Cornelia Amălinei

    Journal: Diagnostics

    Year: 2024

    Type: Article • Open Access

Stavroula Antonopoulou | Prosthodontics | Best Researcher Award

Dr. Stavroula Antonopoulou | Prosthodontics | Best Researcher Award

Assistant Professor at University of Pittsburgh, United States

Dr. Stavroula Antonopoulou, DDS, MS, is a distinguished prosthodontist and Assistant Professor at the University of Pittsburgh School of Dental Medicine. With advanced training from Texas A&M and a Master’s in Oral Biology, her research focuses on digital dentistry and 3D-printed prosthodontic materials. She has published in reputable journals such as the Journal of Prosthetic Dentistry and Prosthesis MDPI, and serves as a reviewer for leading dental journals. As a course director and thesis advisor, she significantly contributes to academic development in digital prosthodontics. Dr. Antonopoulou’s clinical, teaching, and research excellence is reflected in her awards, including the Omicron Kappa Upsilon Faculty Award and the SCAD Award of Merit. Her work in marginal fit and digital dental technologies demonstrates innovation and impact, making her a strong candidate for the Best Researcher Award. Her dedication to education, scholarly contribution, and patient care underscores her suitability for this prestigious recognition.

Professional Profile 

Education🎓

Dr. Stavroula Antonopoulou has pursued an exceptional educational journey that reflects her dedication to dental science and academic excellence. She earned her Doctor of Dental Surgery (DDS) degree from the University of Athens, Greece, laying a strong foundation in clinical dentistry. Driven by a passion for specialization and research, she continued her education in the United States, completing a three-year residency program in Prosthodontics at Texas A&M University College of Dentistry. There, she also obtained a Master of Science (MS) degree in Oral Biology, with her research focusing on digital technologies in prosthodontics and the marginal fit of 3D-printed provisional restorations. Her advanced training and academic background have equipped her with deep expertise in restorative dentistry, digital workflows, and prosthodontic materials. This comprehensive education has not only enhanced her clinical capabilities but also enabled her to contribute significantly to academic research and teaching in the field of digital and fixed prosthodontics.

Professional Experience📝

Dr. Stavroula Antonopoulou has accumulated extensive professional experience that spans clinical practice, academic research, and teaching. Following the completion of her Doctor of Dental Surgery degree in Athens, Greece, she practiced general dentistry, gaining hands-on experience in various restorative procedures. Her professional journey advanced significantly after completing a specialized residency in Prosthodontics at Texas A&M University College of Dentistry, where she also earned a Master’s degree in Oral Biology. During this time, she engaged in research focused on digital prosthodontics, particularly exploring the fit of 3D-printed provisional restorations. Currently, Dr. Antonopoulou serves as a Clinical Assistant Professor in the Department of Restorative Sciences at Texas A&M, where she teaches both predoctoral and postgraduate students. Her role includes supervising clinical cases, conducting research, and integrating digital dentistry into the curriculum. Through her combined clinical and academic experience, she has become a recognized contributor to the advancement of modern prosthodontic education and patient care.

Research Interest🔎

Dr. Stavroula Antonopoulou’s research interests center on the integration of digital technology into prosthodontics and restorative dentistry. She is particularly focused on the clinical accuracy and efficacy of 3D-printed dental restorations, investigating how digital workflows can improve the fit, function, and aesthetics of provisional and final prostheses. Her work explores the dynamic interaction between materials science and digital fabrication techniques, aiming to optimize outcomes in implant-supported restorations. Additionally, she is interested in evidence-based clinical protocols that enhance the predictability of treatment outcomes in prosthodontics. Dr. Antonopoulou is also engaged in educational research, seeking innovative ways to incorporate digital dentistry into dental curricula to better prepare future practitioners. By bridging the gap between clinical practice and emerging technologies, her research contributes to both improving patient care and advancing dental education. Her dedication to research reflects a commitment to innovation and excellence in restorative and prosthetic dental sciences.

Award and Honor🏆

Dr. Stavroula Antonopoulou has received numerous awards and honors that reflect her dedication to excellence in dental research and education. Her work has been recognized both nationally and internationally, highlighting her contributions to prosthodontics and digital dentistry. She has been honored for her innovative research on the accuracy of 3D-printed dental restorations and her commitment to advancing evidence-based clinical practices. Dr. Antonopoulou has received accolades from esteemed dental associations and academic institutions for her scholarly achievements and outstanding presentations at professional conferences. In addition to her research accomplishments, she has been commended for her contributions to dental education, particularly in integrating digital technologies into the curriculum. These honors serve as a testament to her leadership, academic rigor, and impact in the field of restorative dentistry. Her recognition underscores the value of her work in shaping the future of prosthodontics and enhancing the quality of dental care and education worldwide.

Research Skill🔬

Dr. Stavroula Antonopoulou possesses a comprehensive set of research skills that underscore her expertise in prosthodontics and digital dentistry. Her proficiency in experimental design, data analysis, and critical evaluation enables her to conduct high-quality, evidence-based research. She is skilled in utilizing advanced digital technologies, including 3D scanning, CAD/CAM systems, and additive manufacturing, to investigate the precision and clinical outcomes of dental restorations. Dr. Antonopoulou demonstrates strong literature review capabilities and excels in synthesizing complex information to identify research gaps and formulate innovative hypotheses. Her ability to collaborate across multidisciplinary teams enhances her effectiveness in both laboratory and clinical research settings. Furthermore, she is adept at scientific writing, grant proposal preparation, and disseminating findings through peer-reviewed publications and conference presentations. These skills not only support her ongoing academic contributions but also reinforce her role as a thought leader in integrating technological advancements into restorative dental practices.

Conclusion💡

Dr. Stavroula Antonopoulou demonstrates all the essential qualities of a top-tier researcher in the field of prosthodontics and digital dentistry:

✅ Advanced academic credentials
✅ Peer-reviewed publications and journal reviewing roles
✅ Leadership in education and mentorship
✅ Recognition through awards and society membership
✅ Clear contributions to modern prosthodontic innovation

While she could further strengthen her research profile through larger-scale publications and interdisciplinary work, she is highly deserving and strongly suitable for the Best Researcher Award, especially within the dental sciences and digital prosthodontics domains.

Publications Top Noted✍️

  • Title: Effect of different storage conditions on the fit of 3D-printed occlusal devices used to treat temporomandibular disorders

    • Authors: S. Antonopoulou, S.H. Cho, M. Kesterke, E. Kontogiorgos, D. Korentzelos

    • Journal: The Journal of Prosthetic Dentistry, Volume 128, Issue 3, Pages 488.e1–488.e9

    • Year: 2022

    • Citations: 5

  • Title: Effect of Different Storage Environments on Dimensional Stability of Occlusal Devices Made by 3D Printing Technology

    • Author: S. Antonopoulou

    • Year: 2021

Xiaoping Ren | Health Professions | Best Innovation Award

Prof. Dr. Xiaoping Ren | Health Professions | Best Innovation Award

Professor at Lisnom Health, CA, United States

Professor Xiaoping Ren is a globally renowned medical innovator and a leading figure in spinal cord injury treatment and regenerative medicine. As the Chief Scientist of the Global Initiative for the Cure of Paraplegia and Chief Scientific Officer of Lisnom Health, USA, he has pioneered groundbreaking procedures such as the world’s first cephalosomatic anastomosis (head-body transplant) in a mouse model and developed the revolutionary Spinal Cord Fusion (SCF/GEMINI Protocol) using PEG cocktails. With over 70 high-impact SCI publications, multiple international patents, and prestigious awards including the X-PRIZE for life extension, Professor Ren’s contributions have significantly advanced neurosurgery and reconstructive microsurgery. He holds leadership roles at Guangxi University of Chinese Medicine and has served in academic and clinical positions across top institutions in China and the USA. His visionary research and clinical innovations make him a highly deserving candidate for the Best Innovation Award, representing true excellence in medical science and translational impact.

Professional Profile 

Education🎓

Professor Xiaoping Ren has a distinguished educational background that laid the foundation for his groundbreaking medical innovations. He began his medical education in China, where he developed a strong interest in orthopedic surgery and microsurgery. His pursuit of advanced knowledge led him to internationally recognized institutions, including training and fellowships in hand microsurgery at the Kleinert Hand Center, University of Louisville School of Medicine, USA. Throughout his academic journey, Professor Ren has continuously expanded his expertise by engaging in rigorous clinical research and translational medicine. He has held academic roles at the University of Cincinnati and the University of Chicago, where he contributed to the development of cutting-edge surgical techniques. His academic appointments and training in both China and the United States have provided him with a unique cross-cultural and multidisciplinary perspective. This robust educational background has been instrumental in shaping his leadership in spinal cord regeneration and complex reconstructive surgery worldwide.

Professional Experience📝

Professor Xiaoping Ren has over three decades of exceptional professional experience in orthopedic surgery, reconstructive microsurgery, and translational medical research. He began his clinical career in 1984 at Harbin First Hospital, advancing through roles from Resident to Deputy Director of Orthopedics. His international journey includes pivotal academic and clinical positions in the United States, such as Hand Fellow at the University of Louisville, and Assistant/Associate Professor at the University of Cincinnati. He also served as Adjunct Professor and Laboratory Director at the University of Chicago’s Medical Transformation Center. From 2012 to 2018, he held senior roles at Harbin Medical University, leading departments in orthopedics and hand microsurgery. Currently, he is a Professor and Director at Guangxi University of Chinese Medicine and its affiliated Ruikang Hospital. Professor Ren’s extensive global experience has fueled his leadership in groundbreaking innovations, including spinal cord fusion and head-body transplantation models, making him a transformative figure in modern medicine.

Research Interest🔎

Professor Xiaoping Ren’s research interests lie at the forefront of regenerative medicine, neurosurgery, and advanced microsurgical techniques. His primary focus is on spinal cord injury repair and functional restoration through innovative approaches such as the Spinal Cord Fusion (SCF/GEMINI Protocol) using PEG-based cocktails. He is also deeply involved in cephalosomatic anastomosis (head-body transplantation), pushing the boundaries of reconstructive surgery and neural integration. In addition, his work in hand transplantation and peripheral nerve regeneration reflects a broader interest in complex tissue repair and neurovascular reconstruction. Professor Ren is passionate about translational medicine, aiming to bridge experimental breakthroughs with real-world clinical applications. His interdisciplinary approach integrates neuroscience, bioengineering, and clinical surgery to develop life-changing treatments for paralysis and severe trauma. Through global collaborations and cutting-edge experimentation, his research seeks to redefine what is surgically and therapeutically possible in the treatment of catastrophic neurological and musculoskeletal injuries.

Award and Honor🏆

Professor Xiaoping Ren has received numerous prestigious awards and honors in recognition of his groundbreaking contributions to medical science and innovation. He has been honored with the Science and Technology Progress Awards from both the national level in China and the Guangxi regional government for his pioneering work in spinal cord regeneration and reconstructive surgery. Internationally, he was awarded the coveted X-PRIZE for life extension innovations, highlighting his visionary contributions to future-oriented medical solutions. Professor Ren has also been named an influential scientist by the MIT Technology Review, further cementing his global reputation in scientific advancement. He is an Academician of the Russian Academy of Natural Sciences and a Fellow of the International College of Surgeons (USA), accolades that reflect his global impact and leadership in the medical field. His work has been widely featured in international media, including The Wall Street Journal, Discovery Channel, and The New York Times, underscoring his prominence and influence.

Research Skill🔬

Professor Xiaoping Ren possesses an extraordinary range of research skills that have enabled him to lead groundbreaking advancements in regenerative medicine and complex surgical procedures. His expertise spans experimental design, microsurgical techniques, neuroregeneration modeling, and translational research. He is highly skilled in developing innovative protocols, such as the Spinal Cord Fusion (SCF/GEMINI Protocol) using polyethylene glycol (PEG) cocktails, demonstrating his ability to translate molecular-level research into clinical applications. Professor Ren is proficient in conducting animal studies, including cephalosomatic anastomosis models, and has a deep understanding of neural tissue engineering and physiological integration. His capacity to integrate cutting-edge biomedical technologies with surgical practices has led to numerous international patents and high-impact publications. Moreover, his experience in leading multidisciplinary teams and global research collaborations showcases his project management and scientific communication skills. These competencies, combined with his visionary thinking, make him a driving force in medical innovation and a respected leader in international research communities.

Conclusion💡

Professor Xiaoping Ren represents the epitome of medical innovation—fusing bold experimentation, translational science, and global leadership. His SCF/GEMINI Protocol and other pioneering works have the potential to redefine the boundaries of neuroscience, microsurgery, and regenerative medicine.

Publications Top Noted✍️

  • Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, et al.
    2009655 citations
    Title: MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20
    Journal: Circulation 119 (17), 2357–2366

  • Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J, Medvedovic M, Hu Z, et al.
    2010393 citations
    Title: MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury
    Journal: Circulation 122 (13), 1308–1318

  • Diwan A, Krenz M, Syed FM, Wansapura J, Ren X, Koesters AG, Li H, et al.
    2007368 citations
    Title: Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice
    Journal: The Journal of Clinical Investigation 117 (10), 2825–2833

  • Fan GC, Ren X, Qian J, Yuan Q, Nicolaou P, Wang Y, Jones WK, Chu G, et al.
    2005273 citations
    Title: Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury
    Journal: Circulation 111 (14), 1792–1799

  • Jones WK, Brown M, Ren X, He S, McGuinness M
    2003232 citations
    Title: NF-κB as an integrator of diverse signaling pathways: the heart of myocardial signaling?
    Journal: Cardiovascular Toxicology 3, 229–253

  • Francois CG, Breidenbach WC, Maldonado C, Kakoulidis TP, Hodges A, et al.
    2000216 citations
    Title: Hand transplantation: comparisons and observations of the first four clinical cases
    Journal: Microsurgery

  • Luther KM, Haar L, McGuinness M, Wang Y, Lynch IV TL, Phan A, Song Y, et al.
    2018201 citations
    Title: Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells
    Journal: Journal of Molecular and Cellular Cardiology 119, 125–137

  • Fan GC, Zhou X, Wang X, Song G, Qian J, Nicolaou P, Chen G, Ren X, et al.
    2008201 citations
    Title: Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity
    Journal: Circulation Research 103 (11), 1270–1279

  • Jones WK, Fan GC, Liao S, Zhang JM, Wang Y, Weintraub NL, et al.
    2009198 citations
    Title: Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling
    Journal: Circulation 120 (11_suppl_1), S1–S9

  • Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, Li H, Weiss MJ, et al.
    2012166 citations
    Title: Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1
    Journal: Cardiovascular Research 94 (2), 379–390

  • Jones Jr JW, Üstüner ET, Zdichavsky M, Edelstein J, Ren X, Maldonado C, et al.
    1999151 citations
    Title: Long-term survival of an extremity composite tissue allograft with FK506–mycophenolate mofetil therapy
    Journal: Surgery 126 (2), 384–388

  • Qian J, Ren X, Wang X, Zhang P, Jones WK, Molkentin JD, Fan GC, et al.
    2009147 citations
    Title: Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death
    Journal: Circulation Research 105 (12), 1223–1231

Liying Zhang | Medicine and Dentistry | Best Researcher Award

Dr. Liying Zhang | Medicine and Dentistry | Best Researcher Award

Professor at University of California, Los Angeles, United States

Dr. Liying Zhang, MD, PhD, FACMG, is a distinguished researcher and professor specializing in molecular diagnostics and precision oncology. She serves as the Director of the Advanced Molecular Diagnostics Service at UCLA David Geffen School of Medicine and the Director of Cancer Molecular Diagnostics at UCLA Jonsson Comprehensive Cancer Center. With extensive experience in molecular genetics, her research focuses on cancer diagnostics, biomarker discovery, and precision medicine. She has contributed to numerous high-impact studies, secured significant research funding, and played an active role in national and international expert committees. Her expertise spans clinical molecular genetics, genomics, bioinformatics, and laboratory medicine, making her a leading figure in the field of cancer molecular diagnostics.

Professional Profile 

Education

Dr. Zhang earned her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University in 2003, alongside a Master’s degree in Computer Science with a focus on Bioinformatics in 2002. She obtained her MD from Peking University, Beijing, China, in 1994. She holds multiple clinical licensures and board certifications, including Clinical Molecular Genetics and Genomics from the American Board of Medical Genetics and Genomics. Her strong educational foundation in medicine, biochemistry, molecular biology, and computational science has equipped her with the interdisciplinary expertise required for advancing molecular diagnostics and precision medicine.

Professional Experience

Dr. Zhang has held several prestigious roles in molecular pathology and diagnostics. Since 2020, she has been a Professor and Director at UCLA, leading advanced molecular diagnostics initiatives. Previously, she served as a Director and Molecular Geneticist at Memorial Sloan Kettering Cancer Center from 2005 to 2019, overseeing diagnostic molecular genetics laboratories and contributing to groundbreaking cancer research. Her earlier roles include research positions at the National Research Institute for Family Planning in China. Additionally, she has been actively involved in professional committees, journal reviews, and mentorship programs, furthering advancements in molecular diagnostics and genetic research.

Research Interest

Dr. Liying Zhang’s research focuses on molecular diagnostics, cancer genomics, and precision oncology. She is dedicated to identifying genetic biomarkers that enhance cancer detection, prognosis, and treatment strategies. Her work involves integrating next-generation sequencing (NGS) technologies, bioinformatics, and molecular pathology to improve the accuracy and efficiency of cancer diagnostics. She is particularly interested in the molecular mechanisms underlying tumor development, drug resistance, and targeted therapies. Through collaborations with oncologists, geneticists, and data scientists, she aims to translate genetic findings into clinically actionable insights that improve patient outcomes. Her research also extends to liquid biopsy, epigenetics, and the development of novel molecular assays for early cancer detection.

Awards and Honors

Dr. Zhang has received numerous prestigious awards recognizing her contributions to molecular genetics and cancer diagnostics. She has been honored as a Fellow of the American College of Medical Genetics and Genomics (FACMG), acknowledging her leadership and expertise in clinical molecular genetics. She has also received research excellence awards from institutions such as Memorial Sloan Kettering Cancer Center and UCLA for her groundbreaking work in cancer molecular diagnostics. Additionally, she has been an invited speaker at leading international conferences, including the American Society of Human Genetics (ASHG) and the Association for Molecular Pathology (AMP). Her contributions to scientific research and clinical practice have earned her recognition as a thought leader in precision medicine and molecular oncology.

Research Skills

Dr. Zhang possesses a diverse range of research skills in molecular diagnostics and genomics. She is proficient in next-generation sequencing (NGS) technologies, whole-genome and transcriptome analysis, and single-cell sequencing. She has extensive experience in bioinformatics, data mining, and computational modeling for genetic variant interpretation. Her expertise includes designing and validating molecular assays for clinical diagnostics, including PCR-based and hybrid capture-based sequencing methods. She is also skilled in laboratory management, regulatory compliance, and quality control in clinical molecular genetics laboratories. Additionally, her strong background in translational research allows her to bridge the gap between basic scientific discoveries and clinical applications, ensuring that her findings have a direct impact on patient care and personalized treatment strategies.

Conclusion

Dr. Liying Zhang is highly suitable for the Best Researcher Award due to her exceptional contributions to molecular diagnostics, cancer genomics, and precision medicine. Her extensive experience in research leadership, grant acquisition, and clinical applications makes her an outstanding candidate. Strengthening her independent research leadership and international collaborations would further solidify her candidacy for this prestigious award.

Publications Top Noted

  • Title: Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Authors: CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, …
    Year: 2016
    Citation: 1765

  • Title: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    Authors: L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw
    Year: 2010
    Citation: 1402

  • Title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    Authors: L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, …
    Year: 2015
    Citation: 1399

  • Title: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
    Authors: IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, …
    Year: 2009
    Citation: 792

  • Title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    Authors: J Holzbeierlein, P Lal, E LaTulippe, A Smith, J Satagopan, L Zhang, …
    Year: 2004
    Citation: 708

  • Title: Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Authors: A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, …
    Year: 2019
    Citation: 591

  • Title: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Authors: W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, …
    Year: 2017
    Citation: 583

  • Title: Celiac disease: summary
    Authors: A Rostom, C Dubé, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, …
    Year: 2004
    Citation: 511

  • Title: Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Authors: D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, …
    Year: 2017
    Citation: 508

  • Title: Tumour lineage shapes BRCA-mediated phenotypes
    Authors: P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, …
    Year: 2019
    Citation: 384

  • Title: Hereditary diffuse gastric cancer: updated clinical practice guidelines
    Authors: VR Blair, M McLeod, F Carneiro, DG Coit, JL D’Addario, JM van Dieren, …
    Year: 2020
    Citation: 381

  • Title: Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
    Authors: E Chow, P Hoskin, G Mitera, L Zeng, S Lutz, D Roos, C Hahn, …
    Year: 2012
    Citation: 374

  • Title: Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data
    Authors: S Middha, L Zhang, K Nafa, G Jayakumaran, D Wong, HR Kim, …
    Year: 2017
    Citation: 363

  • Title: Genetic predictors of response to systemic therapy in esophagogastric cancer
    Authors: YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, …
    Year: 2018
    Citation: 352

Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Dr.Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Doctor of Medicine at Guilan University Of Medical Sciences, Iran

Mohammad-Hossein Keivanlou is a dedicated medical researcher currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences, Iran. With a strong background in medical research and epidemiology, he has gained proficiency in data analysis, scientific writing, and systematic reviews using tools like R, Stata, SPSS, and VOSviewer. Keivanlou has contributed significantly to medical research, earning the “Best Medical Researcher Award” for 2023 and 2024. He has also been recognized for his academic achievements, ranking 7th in the nationwide Pre-Internship Examination in Iran. As a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center, he has gained valuable hands-on experience, while also mentoring and educating junior medical students in research methodologies. His passion for education, mentorship, and global health research highlights his commitment to both personal growth and advancing medical knowledge.

Professional Profile

Education

Mohammad-Hossein Keivanlou is currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences in Rasht, Iran, a program he has been enrolled in since October 2017. Prior to this, he completed his high school education at the Elite Foundation of Iran, under the National Organization for the Development of Exceptional Talents (Sampad), graduating in October 2017. His academic journey reflects a strong commitment to medical education and research, laying a solid foundation for his future career as a medical researcher and clinician.

Professional Experience

Mohammad-Hossein Keivanlou has gained significant professional experience in the field of medical research. From October 2018 to October 2020, he served as a Medical Research Assistant at Guilan University of Medical Sciences, where he supported research projects and gained hands-on experience in scientific studies. Since October 2020, he has been working as a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center in Rasht, Iran, where he manages and coordinates clinical research projects, ensuring their smooth execution and adherence to scientific standards. These roles have equipped him with valuable skills in research management, data analysis, and collaboration within the medical research community.

Research Interest

Mohammad-Hossein Keivanlou has a strong research interest in medical research and epidemiology, with a particular focus on exploring disease patterns and contributing to global health through evidence-based studies. His work aims to deepen understanding of various health conditions, particularly within the realms of gastrointestinal and liver diseases, while also advancing knowledge on effective public health strategies. In addition to his core research, he is passionate about mentorship and education, helping to guide and inspire the next generation of medical researchers through training and collaborative learning environments. His broad academic interests reflect a commitment to improving health outcomes and promoting scientific advancements in medicine.

Award and Honor

Mohammad-Hossein Keivanlou has received several prestigious awards and honors in recognition of his outstanding contributions to medical research and academic excellence. Notably, he was awarded the “Best Medical Researcher Award” at Guilan University of Medical Sciences for both 2023 and 2024, honoring his significant achievements in medical research, particularly in epidemiology. In addition to this, he ranked 7th nationwide in the 2024 Pre-Internship Examination in Iran, underscoring his academic prowess. Keivanlou was also recognized for his exceptional presentation skills, earning the “Best Presenter” awards at both the Babol Congress 2023 (Nutrition Panel) and Shahid Beheshti Congress 2023 (Cancer Panel). These accolades reflect his dedication to advancing medical knowledge and his reputation as a leader in his field.

Conclusion

Mohammad-Hossein Keivanlou has already demonstrated exceptional abilities in medical research, clinical coordination, and mentoring. His technical skills and passion for research, combined with his recognitions and awards, make him a strong contender for the Best Researcher Award. By further expanding his publication record and leadership roles, he could solidify his place as a leader in the field.

Publications Top Noted
  • Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: An umbrella review on meta-analyses
    • Authors: Habibi, A., Letafatkar, N., Sattari, N., Keivanlou, M.-H., Amini-Salehi, E.
    • Year: 2025
    • Citation: Clinical Nutrition ESPEN, 65, pp. 93–104
    • Citations: 0
  • The evolving role of MRI in the detection of extrathyroidal extension of papillary thyroid carcinoma: A systematic review and meta-analysis
    • Authors: Javid, M., Mirdamadi, A., Javid, M., Mansour-Ghanaei, F., Hassanipour, S.
    • Year: 2024
    • Citation: BMC Cancer, 24(1), 1531
    • Citations: 0
  • The association between neutrophil and lymphocyte to high-density lipoprotein cholesterol ratio and metabolic syndrome among Iranian population, finding from Bandare Kong cohort study
    • Authors: Hashemi, S.M., Kheirandish, M., Rafati, S., Saberian, P., Rahimi, A.
    • Year: 2024
    • Citation: Lipids in Health and Disease, 23(1), 393
    • Citations: 0
  • Diagnostic and prognostic value of triglyceride glucose index: A comprehensive evaluation of meta-analysis
    • Authors: Nayak, S.S., Kuriyakose, D., Polisetty, L.D., Hassanipour, S., Amini-Salehi, E.
    • Year: 2024
    • Citation: Cardiovascular Diabetology, 23(1), 310
    • Citations: 9
  • Correction: The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 67
    • Citations: 0
  • The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 25
    • Citations: 4
  • Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: An umbrella review on meta-analyses
    • Authors: Mahapatro, A., Nobakht, S., Mukesh, S., Amini-Salehi, E., Nayak, S.S.
    • Year: 2024
    • Citation: European Journal of Medical Research, 29(1), 210
    • Citations: 3
  • Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: An umbrella review
    • Authors: Nayak, S.S., Amini-Salehi, E., Joukar, F., Hassanipour, S., Keivanlou, M.-H.
    • Year: 2024
    • Citation: International Journal of Surgery, 110(11), pp. 7367–7380
    • Citations: 0
  • Global prevalence of nonalcoholic fatty liver disease: An updated meta-analysis on 78 million population over 38 countries
    • Authors: Amini-Salehi, E., Letafatkar, N., Norouzi, N., Patel, D., Nayak, S.S.
    • Year: 2024
    • Citation: Archives of Medical Research, 55(6), 103043
    • Citations: 5
  • Exploring the relationship between gut microbiome modulation and blood pressure in type 2 diabetes: An umbrella review
    • Authors: Amini-Salehi, E., Mahapatro, A., Korsapati, R.R., Keivanlou, M.-H., Patel, D.
    • Year: 2024
    • Citation: Nutrition, Metabolism and Cardiovascular Diseases, 34(9), pp. 2046–2054
    • Citations: 4